natgillin/translations-raw huggingface dataset:
Jirova, D., Liebsch, M., Basketter, D., Spiller, E., Kejlova, K., Bendova, H., Marriott, M. and Kandarova, H. (2007), Comparison of human skin irritation and photo-irritation patch test data with cellular in vitro assays and animal in vivo data, ALTEX, 14, 359-365.
Jirova, D., Liebsch, M., Basketter, D., Spiller, E., Kejlova, K., Bendova, H., Marriott, M. and Kandarova, H. (2007), Comparison of human skin irritation and photo-irritation patch test data with cellular in vitro assays and animal in vivo data, ALTEX, 14, 359–365.
In addition to using the MNvit assay to identify chemicals (substances and mixtures) that induce micronuclei, the use of a cytokinesis block, immunochemical labelling of kinetochores, or hybridisation with centromeric/telomeric probes (fluorescence in situ hybridisation (FISH)), also can provide information on the mechanisms of chromosome damage and micronucleus formation (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16).
Ob uporabi analize mikronukleusov in vitro za opredelitev kemikalij (snovi in zmesi), ki spodbujajo nastanek mikronukleusov, se lahko z uporabo citokinetskega bloka, imunokemijskega označevanja kinetohor ali hibridizacije s centromerno/telomerno sondo (fluorescenčna in situ hibridizacija (FISH)) prav tako pridobijo informacije o mehanizmih poškodb kromosomov in nastanka mikronukleusov (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16).
The labelling and hybridisation procedures can be used when there is an increase in micronucleus formation and the investigator wishes to determine if the increase was the result of clastogenic and/or aneugenic events.
Postopek označevanja in hibridizacije se lahko uporabi v primeru povečanega nastajanja mikronukleusov, ko želi raziskovalec ugotoviti, ali je povečanje nastalo zaradi dogodkov, ki povzročajo strukturne in številčne poškodbe kromosomov (klastogenih in/ali anevgenih dogodkov).
The use of a DNA specific stain (e.g. acridine orange (61) or Hoechst 33258 plus pyronin-Y (62)) can eliminate some of the artefacts associated with using a non-DNA specific stain.
Uporaba DNA-specifičnega barvila (npr. akridin oranž (61) ali Hoechst 33258 plus pyronin-Y (62)) lahko prepreči nastanek nekaterih artefaktov, povezanih z uporabo barvila, ki ni specifično za DNA.
Anti-kinetochore antibodies, FISH with pancentromeric DNA probes, or primed in situ labelling with pancentromere-specific primers, together with appropriate DNA counterstaining, can be used to identify the contents (chromosome/chromosomal fragment) of micronuclei if mechanistic information of their formation is of interest (15) (16).
Za opredelitev vsebine (kromosom/kromosomski delec) mikronukleusov, če so potrebne mehanske informacije o njihovi tvorbi, se lahko uporabi kinetohorno protitelo, fluorescentna in situ hibridizacija (FISH) s sondami DNA za centromere ali primarno označevanje in situ s premazi, specifičnimi za centromere, skupaj z ustreznim nasprotnim barvanjem DNA (15) (16).
Other methods for differentiation between clastogens and aneugens may be used if they have been shown to be effective.
Za razlikovanje med snovmi, ki povzročajo strukturne in številčne poškodbe kromosomov (anevgeni in klastogeni), se lahko uporabijo druge metode, če so se izkazale za učinkovite.
Fenech, M. (2007), Cytokinesis-block micronucleus cytome assay, Nature Protocols, 2(5), 1084-1104.
Fenech, M. (2007), Cytokinesis-block micronucleus cytome assay, Nature Protocols, 2(5), 1084–1104.
Health, 53 563-79.
Health, 53563–79.
In addition, chemical classes or substances containing functional groups shown to act as potential confounders (15) may necessitate the use of guinea pig tests (i.e. B.6; OECD Test Guideline 406 (13)).
Poleg tega je zaradi kemijskih razredov ali snovi s funkcionalnimi skupinami, za katere se je izkazalo, da lahko delujejo kot moteči dejavniki (15), lahko potrebna uporaba preskusov na morskih prašičkih (tj. B.6; Smernica za preskušanje OECD 406 (13)).
Limitations that have been identified for the LLNA (1 and Chapter B.42 in this Annex) have been recommended to apply also to the LLNA: BrdU-ELISA (10).
Za omejitve, določene za LLNA (1 in poglavje B.42 te priloge), je bilo priporočeno, da se uporabljajo tudi za analizo LLNA: BrdU-ELISA (10).
Other than such identified limitations, the LLNA: BrdU-ELISA should be applicable for testing any chemicals unless there are properties associated with these chemicals that may interfere with the accuracy of the LLNA: BrdU-ELISA.
Razen takšnih določenih omejitev bi morala biti analiza LLNA: BrdU-ELISA primerna za preskušanje katerih koli kemikalij, razen če so s temi kemikalijami povezane lastnosti, ki lahko ovirajo natančnost analize LLNA: BrdU-ELISA.
In addition, consideration should be given to the possibility of borderline positive results when Stimulation Index (SI) values between 1,6 and 1,9 are obtained (see paragraphs 31-32).
Poleg tega je treba razmisliti o možnosti mejnih pozitivnih rezultatov v primerih, ko so dobljene vrednosti stimulacijskega indeksa (SI) med 1,6 in 1,9 (glej odstavke 31–32).
This is based on the validation database of 43 substances using an SI ≥ 1,6 (see paragraph 6) for which the LLNA: BrdU-ELISA correctly identified all 32 LLNA sensitisers, but incorrectly identified two of 11 LLNA non-sensitisers with SI values between 1,6 and 1,9 (i.e. borderline positive) (10).
To temelji na podatkovni zbirki za validacijo s 43 snovmi s stimulacijskim indeksom ≥ 1,6 (glej odstavek 6), pri kateri je analiza LLNA: BrdU-ELISA pravilno opredelila vseh 32 povzročiteljev preobčutljivosti pri LLNA, vendar je nepravilno opredelila dve od 11 snovi, ki pri LLNA ne povzročajo preobčutljivosti z vrednostmi stimulacijskega indeksa med 1,6 in 1,9 (tj. mejno pozitivna vrednost) (10).
A reduced LLNA (rLLNA) approach, which could use up to 40 % fewer animals is also described as an option in this TM (16) (17) (18). The rLLNA may be used when there is a regulatory need to confirm a negative prediction of skin sensitising potential, provided there is adherence to all other LLNA protocol specifications, as described in this TM.
Pristop omejene LLNA (rLLNA), pri katerem bi se lahko uporabilo do 40 % manj živali, je prav tako opisan kot možnost v tej preskusni metodi (16) (17) (18). rLLNA se lahko uporabi, kadar obstaja zakonodajna potreba po potrditvi negativne napovedi o morebitni preobčutljivosti kože, če so izpolnjene vse druge specifikacije protokola LLNA, kot je opisano v tej preskusni metodi.
Prediction of a negative outcome should be made based on all available information as described in paragraph 4. Before applying the rLLNA approach, clear justifications and scientific rationale for its use should be provided.
Napoved negativnega rezultata bi morala temeljiti na vseh razpoložljivih informacijah, kot je opisano v odstavku 4.
The term is used interchangeably with accuracy, and is defined as the proportion of all chemicals tested that are correctly classified as positive or negative.
Izraz se izmenično uporablja z natančnostjo in je opredeljen kot delež vseh preskušanih kemikalij, ki so pravilno razvrščene kot pozitivne ali negativne.
Hoffman, W.P., Garriott, M.L. and Lee, C. (2003), In vitro micronucleus test, In: Encyclopedia of Biopharmaceutical Statistics, Second edition.
Hoffman, W.P., Garriott, M.L. and Lee, C. (2003), In vitro micronucleus test, v: Encyclopedia of Biopharmaceutical Statistics, Second edition.
UNEP (2001), Stockholm Convention on Persistent Organic Pollutants, United Nations Environment Programme (UNEP).
UNEP (2001), Stockholm Convention on Persistent Organic Pollutants, United Nations Environment Programme (UNEP).
, CHO/HGPRT Mutation Assay: Evaluation of Gases and Volatile Liquids, In: Tice, R.R., Costa, D.L. and Schaich, K.M.
, CHO/HGPRT Mutation Assay: Evaluation of Gases and Volatile Liquids, v: Tice, R.R., Costa, D.L. and Schaich, K.M.
However, it might be more appropriate to follow Option A for stimulated lymphocytes where exponential growth may be declining at 96 hrs following stimulation. Also, cultures of cells should not have reached confluence by the final sampling time in Option B.
Vendar je za stimuliranje limfocitov, pri katerih se lahko eksponentna rast po 96 urah po stimulaciji zmanjšuje, morda primernejša možnost A. Pri možnosti B celične kulture do končnega časa vzorčenja ne smejo postati strjene.
Van Och, F.M.M., Slob, W., De Jong, W.H., Vandebriel, R.J. and Van Loveren, H. (2000), A quantitative method for assessing the sensitising potency of low molecular weight chemicals using a local lymph node assay: employment of a regression method that includes determination of uncertainty margins.
Van Och, F.M.M., Slob, W., De Jong, W.H., Vandebriel, R.J. and Van Loveren, H. (2000), A quantitative method for assessing the sensitising potency of low molecular weight chemicals using a local lymph node assay: employement of a regression method that includes determination of uncertainty margins.
Bonassi, S., Fenech, M., Lando, C., Lin, Y.P., Ceppi, M., Chang, W.P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., Bigatti, M.P., Bolognesi, C., Jia, C., Di Giorgio, M., Ferguson, L.R., Fucic, A., Lima, O.G., Hrelia, P., Krishnaja, A.P., Lee, T.K., Migliore, L., Mikhalevich, L., Mirkova, E., Mosesso, P., Muller, W.U., Odagiri, Y., Scarffi, M.R., Szabova, E., Vorobtsova, I., Vral, A. and Zijno, A. (2001), HUman MicroNucleus Project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes, I. Effect of laboratory protocol, scoring criteria and host factors on the frequency of micronuclei, Environ.
Bonassi, S., Fenech, M., Lando, C., Lin, Y.P., Ceppi, M., Chang, W.P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., Bigatti, M.P., Bolognesi, C., Jia, C., Di Giorgio, M., Ferguson, L.R., Fucic, A., Lima, O.G., Hrelia, P., Krishnaja, A.P., Lee, T.K., Migliore, L., Mikhalevich, L., Mirkova, E., Mosesso, P., Muller, W.U., Odagiri, Y., Scarffi, M.R., Szabova, E., Vorobtsova, I., Vral, A. and Zijno, A. (2001), HUman MicroNucleus Project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes, I. Effect of laboratory protocol, scoring criteria and host factors on the frequency of micronuclei, Environ.
Cytotoxicity should be determined with and without metabolic activation in cells that require metabolic activation using the relative increase in cell counts (RICC) or relative population doubling (RPD) (see Appendix 2 for formulas) unless cytoB is used. When cytoB is used, cytotoxicity can be determined using the replication index (RI) (see Appendix 2 for formula).
Citotoksičnost se določa z aktivacijo presnove in brez nje v celicah, pri katerih je aktivacija presnove potrebna, in sicer z uporabo relativnega povečanja števila celic (relative increase in cell counts, RICC) ali relativne podvojitve populacije (relative population doubling, RPD) (glej Dodatek 2 za formule), razen če se uporabi citohalazin B. Če se uporabi citohalazin B, se lahko citotoksičnost določi z indeksom pomnoževanja (RI) (glej Dodatek 2 za formulo).
To ensure that a similar or modified LLNA method is functionally and mechanistically analogous to the LLNA and measures the same biological effect, the following components should be included in the test method protocol: The test substance should be applied topically to both ears of the mouse;
Za zagotovitev, da je podobna ali spremenjena metoda LLNA v funkcijskem in mehaničnem smislu podobna LLNA in meri isti biološki učinek, morajo biti v protokol preskusne metode vključeni naslednji elementi:
The MNvit assay is robust and effective in a variety of cell types, and in the presence or absence of cytoB. There are extensive data to support the validity of the MNvit assay using various rodent cell lines (CHO, V79, CHL/IU, and L5178Y) and human lymphocytes (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31).
Analiza mikronukleusov in vitro je zanesljiva in učinkovita pri različnih vrstah celic ter ob prisotnosti ali odsotnosti citohalazina B. Na voljo so obširni podatki, ki podpirajo veljavnost analize mikronukleusov in vitro pri različnih celičnih linijah glodavcev (CHO, V79, CHL/IU, in L5178Y) in človeških limfocitih (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31).
Unlike guinea pig tests (i.e. B.6; OECD Test Guideline 406) (13) the LLNA does not require that challenge-induced dermal hypersensitivity reactions be elicited. Furthermore, the LLNA does not require the use of an adjuvant, as is the case for the guinea pig maximisation test (13). Thus, the LLNA reduces animal pain and distress. Despite the advantages of the LLNA over B.6 and OECD Test Guideline 406, it should be recognised that there are certain limitations that may necessitate the use of B.6 or OECD Test Guideline 406 (13) (e.g. false negative findings in the LLNA with certain metals, false positive findings with certain skin irritants (such as some surfactant type chemicals) (19) (20), or solubility of the test substance).
V nasprotju s preskusi na morskih prašičkih (tj. B.6; Smernica za preskušanje OECD (406) (13) LLNA ne zahteva, da se povzročijo izzvane reakcije prekomerne občutljivosti kože. Poleg tega LLNA ne zahteva uporabe pomožnega preskusa (13) kot pri maksimizacijskem preskusu na morskih prašičkih S tem LLNA zmanjšuje bolečino in trpljenje živali. Kljub prednostim LLNA v primerjavi z metodo B.6 in Smernico za preskušanje OECD 406 je treba upoštevati, da obstajajo nekatere omejitve, zaradi katerih je lahko nujna uporaba metode B.6 ali Smernice za preskušanje OECD 406 (13) (npr. lažni negativni izidi pri LLNA pri nekaterih kovinah, lažni pozitivni izidi pri nekaterih dražilnih snoveh za kožo [kot so nekatere vrste površinsko razgradljivih kemikalij] (19) (20), ali topnost preskusne snovi). Poleg tega je zaradi kemijskih razredov ali snovi s funkcionalnimi skupinami, za katere se je izkazalo, da lahko delujejo kot moteči dejavniki (21) lahko potrebna uporaba preskusov na morskih prašičkih (tj. B.6; Smernica za preskušanje OECD 406) (13). Na podlagi omejene podatkovne zbirke za validacijo, ki je obsegala zlasti pesticidne pripravke, je bolj verjetno, da bo za te vrste snovi pozitiven rezultat prinesla LLNA kot pa preskus na morskih prašičkih (22). Vendar pa bi se lahko pri preskušanju pripravkov preučila tudi možnost vključitve podobnih snovi z znanimi rezultati kot primerjalnih snovi, s čimer bi se dokazalo, da LLNA deluje pravilno (glej odstavek 16). Razen takšnih opredeljenih omejitev bi morala biti LLNA primerna za preskušanje katere koli snovi, razen če so s temi snovmi povezane lastnosti, ki lahko ovirajo natančnost LLNA.
In addition, chemical classes or substances containing functional groups shown to act as potential confounders (21) may necessitate the use of guinea pig tests (i.e. B.6; OECD Test Guideline 406) (13). Further, based on the limited validation database, which consisted primarily of pesticide formulations, the LLNA is more likely than the guinea pig test to yield a positive result for these types of test substances (22). However, when testing formulations, one could consider including similar substances with known results as benchmark substances to demonstrate that the LLNA is functioning properly (see paragraph 16). Other than such identified limitations, the LLNA should be applicable for testing any substances unless there are properties associated with these substances that may interfere with the accuracy of the LLNA. PRINCIPLE OF THE TEST
NAČELO PRESKUSA
Liquid chemicals may be applied neat or diluted prior to dosing. Insoluble chemicals, such as those generally seen in medical devices, should be subjected to an exaggerated extraction in an appropriate solvent to reveal all extractable constituents for testing prior to application to an ear of the mice.
Tekoče kemikalije se lahko nanesejo nerazredčene ali pa se razredčijo pred dajanjem odmerka Pri netopnih kemikalijah, kot so tiste, ki se običajno uporabljajo v medicinskih pripomočkih, je treba uporabiti močno povečano ekstrakcijo v ustreznem topilu, da se odkrijejo vse ekstraktibilne sestavine za preskušanje pred nanosom na uho miši.
The PC dose should be chosen such that it does not cause excessive skin irritation or systemic toxicity and the induction is reproducible but not excessive (i.e. a SI > 20 would be excessive). Preferred PC are 25 % hexyl cinnamic aldehyde (Chemical Abstracts Service (CAS) No 101-86-0) in acetone: olive oil (4:1, v/v) and 5 % mercaptobenzothiazole (CAS No 149-30-4) in N,N-dimethylformamide (see Appendix 1, Table 1).
Odmerek pozitivne kontrole je treba izbrati tako, da ne povzroči čezmernega draženja kože ali sistemske toksičnosti in da je indukcija ponovljiva, vendar ne čezmerna (tj. SI > 20 bi bil čezmeren) Priporočena pozitivna kontrola je 25-odstotni heksil cimetov aldehid (Služba za izmenjavo kemijskih izvlečkov [CAS] št. 101-86-0) v acetonu: olivno olje (4:1, v/v) in 5-odstotni merkaptobenzotiazol (št. CAS 149-30-4) v N,N-dimetilformamidu (glej Dodatek 1, preglednica 1).
Reference chemicals recommended for assessing performance [1] Category
Referenčne kemikalije, priporočene za ocenjevanje učinkovitosti [1]Kategorija
The PC dose should be chosen such that it does not cause excessive skin irritation or systemic toxicity and the induction is reproducible but not excessive (e.g. SI > 10 would be considered excessive). Preferred PC are 25 % hexyl cinnamic aldehyde (Chemical Abstracts Service (CAS) number 101-86-0) and 25 % eugenol (CAS number 97-53-0) in acetone: olive oil (4:1, v/v).
Odmerek pozitivne kontrole je treba izbrati tako, da ne povzroči čezmernega draženja kože ali sistemske toksičnosti in da je indukcija ponovljiva, vendar ne čezmerna (tj. SI > 10 bi se štel za čezmernega) Priporočena pozitivna kontrola je 25-odstotni heksil cimetov aldehid (Služba za izmenjavo kemijskih izvlečkov [CAS] št. 101-86-0) in 25-odstotni evgenol (št. CAS 97-53-0) v acetonu: olivnem olju (4:1, v/v).
Approximately 24 to 30 hours after the start of application on Day 7, humanely kill the animals. Excise the draining auricular lymph nodes from each mouse ear and process separately in phosphate buffered saline (PBS) for each animal.
Približno 24 do 30 ur po začetku nanašanja 7. dne se živali humano usmrti.
Day 6 Record the weight of each animal and any clinical observation. Approximately 24 hours (24 h) after BrdU injection, humanely kill the animals.
dan Zabeleži se masa vsake živali in morebitne klinične ugotovitve.
Council Regulation (EU) No 641/2012
Uredba Sveta (EU) št. 641/2012
amending Regulation (EU) No 356/2010 imposing certain specific restrictive measures directed against certain natural or legal persons, entities or bodies, in view of the situation in Somalia
o spremembi Uredbe (EU) št. 356/2010 o nekaterih posebnih omejitvenih ukrepih proti nekaterim fizičnim ali pravnim osebam, subjektom ali organom zaradi razmer v Somaliji
Having regard to Council Decision 2010/231/CFSP of 26 April 2010 concerning restrictive measures against Somalia [1],
ob upoštevanju Sklepa Sveta 2010/231/SZVP z dne 26. aprila 2010 o omejitvenih ukrepih proti Somaliji [1],
Regulation (EU) No 356/2010 [2] imposes restrictive measures against the persons entities and bodies identified in Annex I to that Regulation, as provided for in United Nations Security Council Resolution (UNSCR) 1844 (2008).
Uredba (EU) št. 356/2010 [2] določa omejitvene ukrepe proti osebam, subjektom in organom iz Priloge I k navedeni uredbi, kakor je določeno v Resoluciji Varnostnega sveta Združenih narodov (v nadaljnjem besedilu: RVSZN)1844 (2008).
On 22 February 2012, the UN Security Council adopted UNSCR 2036 (2012), by which it confirms its assessment, in paragraph 23, that the export of charcoal from Somalia may pose a threat to the peace, security or stability of Somalia.
Varnostni svet Združenih narodov je 22. februarja 2012 sprejel RVSZN 2036 (2012), s katero je v odstavku 23 potrdil svojo oceno, da lahko izvoz oglja iz Somalije lahko ogroža mir, varnost ali stabilnost v Somaliji.
On 17 February 2012, the Security Council Sanctions Committee established pursuant to UNSCR 751 (1992) concerning Somalia updated the list of persons and entities subject to restrictive measures.
Odbor za sankcije Varnostnega sveta, ustanovljen v skladu s RVSZN 751(1992) glede Somalije, je 17. februarja 2012 posodobil seznam oseb in subjekotv, za katere veljajo omejitveni ukrepi.
On 16 July 2012, the Council adopted Decision 2012/388/CFSP [3], to give effect to UNSCR 751 (1992) by adding one further person to the list of persons and entities subject to the restrictive measures in Decision 2010/231/CFSP.
Svet je z namenom izvajanja RVSZN 751(1992) 16. julija 2012 sprejel Sklep 2012/388/SZVP [3], tako da dodaja dodatno osebo na seznam oseb in subjektov, za katere veljajo omejitveni ukrepi iz Sklepa 2010/231/SZVP.
This measure falls within the scope of the Treaty and regulatory action at the level of the Union is therefore necessary in order to implement it, in particular with a view to ensuring its uniform application by economic operators in all Member States.
Ta ukrep spada na področje uporabe Pogodbe, zato je za njegovo izvajanje potreben regulativni ukrep na ravni Unije predvsem zaradi zagotovitve, da ga bodo gospodarski subjekti v vseh državah članicah enotno uporabljali.
Additionally, UNSCR 2002 (2011) clarified the exemption, already provided for in Regulation (EU) No 356/2010, permitting the making available of funds, other financial assets or economic resources necessary to ensure the timely delivery of urgently needed humanitarian assistance in Somalia by the UN, its specialised agencies or programmes, humanitarian organisations having observer status with the United Nations General Assembly that provide humanitarian assistance, and their implementing partners.
Poleg tega je bila z RVSZN 2002 (2011) razjasnjena izjema, ki je že bila določena z Uredbo (EU) št. 356/2010 in omogoča dajanje na razpolago sredstev, drugih finančnih sredstev ali gospodarskih virov, ki jih za pravočasno dostavo nujno potrebne humanitarne pomoči v Somalijo potrebujejo Združeni narodi, specializirane agencije ali programi Združenih narodov ter humanitarne organizacije s statusom opazovalk pri Generalni skupščini Združenih narodov, ki zagotavljajo humanitarno pomoč, in njihovi izvajalski partnerji.
This clarification should be included in Regulation (EU) No 356/2010.
To razjasnitev bi bilo treba vključiti v Uredbo (EU) št. 356/2010.
Regulation (EU) No 356/2010 should therefore be amended accordingly,
Uredbo Sveta (EU) št. 356/2010 bi bilo zato treba ustrezno spremeniti –
Regulation (EU) No 356/2010 is hereby amended as follows:
Uredba (EU) št. 356/2010 se spremeni:
In Article 2, paragraph 3 is replaced by the following:
v členu 2 se odstavek 3 nadomesti z naslednjim:
Annex I shall consist of natural or legal persons, entities or bodies designated by the Security Council or the Sanctions Committee in accordance with UNSCR 1844 (2008) as:
V Prilogi I so navedene fizične ali pravne osebe, subjekti ali organi, ki jih določi Varnostni svet ali Odbor za sankcije v skladu z RVSZN 1844 (2008), ker:
engaging in or providing support for acts that threaten the peace, security or stability of Somalia, including acts that threaten to infringe the Djibouti Agreement of 18 August 2008 or the political process, or threaten the TFIs or AMISOM by force;
sodelujejo pri dejanjih, ki ogrožajo mir, varnost ali stabilnost Somalije, vključno z dejanji, ki ogrožajo ali kršijo sporazum iz Džibutija z dne 18. avgusta 2008 ali politični proces, ali s silo grozijo prehodnim zveznim institucijam Somalije (TFI) ali misiji Afriške unije v Somaliji (AMISOM), ali za navedena dejanja zagotavljajo podporo;
having acted in violation of the arms embargo and related measures as reaffirmed in paragraph 6 of UNSCR 1844 (2008);
so kršili embargo na orožje in s tem povezane ukrepe, kot je ponovno potrjeno v odstavku 6 RVSZN 1844 (2008);
obstructing the delivery of humanitarian assistance to Somalia, or access to, or distribution of, humanitarian assistance in Somalia;
ovirajo dostavo humanitarne pomoči Somaliji, dostop do nje ali njeno razdeljevanje v Somaliji;